Basic Airomir Information

• INN (International Nonproprietary Name): Albuterol (also known internationally as Salbutamol).
• Brand Names Available In Canada (English): Ventolin, Airomir, Salamol and generic albuterol/salbutamol formulations are referenced globally; specific Canadian brand lists are DIN-linked and vary by supplier.
• ATC Code: R03AC02.
• Forms & Dosages: Metered dose inhaler 90 mcg per actuation (typical 200 actuations per canister), nebulizer solutions 0.083% and 0.5%, and less common oral tablets/syrups (2 mg, 4 mg tablets; 2 mg/5 mL syrup).
• Manufacturers In Canada (English): Global manufacturers include GlaxoSmithKline (Ventolin), Teva, Sandoz, Mylan and others; local Canadian manufacturers and distributors supply DIN-approved products.
• Registration Status In Canada (English): Albuterol/salbutamol products are registered worldwide; specific DIN approvals and provincial formulary listings must be checked for Canada.
• OTC / Rx Classification: Prescription only (Rx) in most jurisdictions, with some pharmacy-level emergency-supply allowances under provincial rules.

Key Findings From Recent Trials

Major 2022–2025 Canadian & Global Studies

What are patients and clinicians most worried about with rescue inhalers?

Recent literature from 2022–2025 emphasises that SABA overuse correlates with higher exacerbation and emergency department visit rates.

Studies from Canadian cohorts and international registries show that using more than two SABA canisters per month is linked to increased healthcare use.

Guideline shifts during the period recommend minimising SABA monotherapy and prioritising inhaled corticosteroid (ICS) or ICS–formoterol controllers for ongoing management.

Randomised trials and meta-analyses through 2024 reinforce that albuterol delivers fast bronchodilation but does not modify underlying airway inflammation.

Main Outcomes

Albuterol provides rapid symptom relief with onset typically within five to fifteen minutes and peak effect around 30–60 minutes.

Nebulized albuterol at standard doses (2.5 mg adults, 1.25–2.5 mg children) gives similar bronchodilation to metered dose inhalers used with a spacer in non-life-threatening situations.

Registry analyses found that patients relying on rescue inhalers more than twice per week often require escalation to controller therapy.

Safety Observations

Post-market safety reviews from 2022–2025 reiterate class adverse events such as tremor, tachycardia and hypokalaemia.

Rare events include paradoxical bronchospasm and cardiac cautions in patients with comorbid heart disease.

MDI dose is typically 90 mcg per actuation and nebulizer dosing remains 2.5 mg standard for adults in acute care settings.

Clinical Mechanism Of Action

Layman’s Explanation

How does Airomir open the airways so quickly?

Airomir, which contains albuterol, relaxes the muscles around the airways to relieve wheeze and shortness of breath quickly.

Think of it as a fast-acting airway opener that eases symptoms but does not treat the underlying inflammation of asthma.

Scientific Breakdown

Albuterol is a selective short-acting β2-adrenergic agonist that stimulates β2 receptors on bronchial smooth muscle.

Activation of β2 receptors increases intracellular cyclic AMP, which leads to smooth muscle relaxation and bronchodilation.

Receptor Pharmacology

Albuterol has relative β2 selectivity, which reduces β1 cardiac effects but does not abolish them.

At higher doses or in sensitive patients, β1 activity can produce palpitations and tachycardia.

Pharmacokinetics (Brief)

Inhaled albuterol gives rapid onset within five to fifteen minutes and a duration typically four to six hours.

Inhaled delivery produces low systemic bioavailability compared with oral forms, lowering systemic adverse effects at standard doses.

Nebulized solutions deliver a larger nominal dose but produce similar clinical bronchodilation when used correctly, especially in acute care.

Scope Of Approved & Off-Label Use

Health Canada Approvals (DIN-Based)

What is Airomir approved for in Canada?

Approved indications mirror global practice: rescue relief for acute bronchospasm in asthma and reversible airway diseases, and prophylaxis for exercise-induced bronchospasm.

Nebulizer solutions are approved for severe exacerbations in settings where nebulization is clinically indicated.

Products in market have DINs tied to specific formulations and strengths, commonly MDI 90 mcg per actuation in 200-actuation canisters.

Notable Off-Label Trends In Canadian Practice

Clinicians frequently use albuterol pragmatically in COPD exacerbations and paediatric nebulized dosing under specialist guidance.

Pharmacists sometimes supply emergency refills according to provincial emergency supply rules across ODB, BC PharmaCare and RAMQ frameworks.

Prescription-only status remains standard, while behind-the-counter allowances and emergency supply rules vary by province.

Dosage Strategy

General Dosing Per Health Canada Monographs

What dose should most patients use for quick relief?

MDI dosing for adults and adolescents is commonly two inhalations of 90 mcg each every four to six hours as needed for acute bronchospasm.

Children aged four years and older generally receive one to two inhalations as needed, per monograph guidance.

Nebulizer dosing is about 2.5 mg per treatment in adults and 1.25–2.5 mg in children depending on age and clinical response.

Condition-Specific Dosing Adjustments

For exercise-induced bronchospasm, administer two inhalations 15–30 minutes before activity.

Elderly patients typically use standard dosing but warrant cardiac cautions and monitoring for side effects.

Children under four require specialist oversight with hospital-approved nebulized regimens commonly used.

Frequent need for SABA (more than two days per week) signals inadequate control and prompts reassessment of controller therapy.

Safety Protocols

Contraindications (Canadian Advisories)

Who should avoid airomir?

Absolute contraindications include known hypersensitivity to albuterol or formulation excipients.

Some MDIs contain lactose, so severe milk-protein hypersensitivity is a noted precaution.

Relative cautions apply to arrhythmias, coronary artery disease, uncontrolled hypertension, hyperthyroidism, seizure disorders and diabetes.

Adverse Effects (Post-Market Reports)

Common side effects reported include tremor, nervousness, headache, throat irritation, cough and tachycardia.

Rare but serious events documented post-market include paradoxical bronchospasm and severe allergic reactions.

Overdose can be life-threatening with pronounced tachycardia, chest pain, severe tremor and hypokalaemia; emergency care is required.

Pharmacists should counsel on spacer use to improve delivery and reduce oropharyngeal deposition.

Interaction Mapping

Food Interactions Common In Canadian Diet

Are there foods that make side effects worse?

No major food interactions are recorded, but caffeine from coffee and energy drinks can increase stimulant side effects like tremor and palpitations.

Drug Combinations Flagged By Health Canada

Non-selective β-blockers such as propranolol antagonise albuterol’s bronchodilator effect and should be avoided when possible.

Concurrent use with other sympathomimetics or monoamine oxidase inhibitors may amplify cardiovascular effects.

Tricyclic antidepressants can increase arrhythmia risk when combined with high-dose albuterol.

Diuretics may worsen hypokalaemia risk; monitor electrolytes in patients on loop or thiazide diuretics who receive high cumulative SABA doses.

Albuterol can transiently raise blood glucose, so review diabetes therapies when appropriate.

Patient Experience Analysis

Canadian Survey Data

What do Canadian patients say about their rescue inhaler?

Surveys from 2022–2025 show patients rely on albuterol for immediate symptom relief and often worry about when to escalate care.

Cost and access remain concerns in some provinces, especially when switching brands affects coverage under provincial plans.

Forum & Community Pharmacy Trends

Community pharmacists report frequent inhaler technique issues and step in with spacer demos and dose counting advice.

Online forums discuss brand preferences such as Ventolin versus Airomir and anxiety over canister life and refill timing.

Pharmacies like Shoppers Drug Mart and Rexall commonly offer inhaler counselling and technique checks as part of patient services.

Distribution & Pricing Landscape

National Pharmacy Chains

Where can patients pick up an inhaler?

Airomir and salbutamol products are stocked through national chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, as well as independent pharmacies.

Provincial formularies list DIN-specific products for coverage under ODB, BC PharmaCare and RAMQ; patients should confirm brand and DIN with their plan.

Online Pharmacy Availability & Provincial Restrictions

Canadian online pharmacies may dispense prescription inhalers when provided with a valid prescription and when shipment complies with interprovincial rules.

Supply and shipping constraints vary by province and may affect turnaround time for refill orders.

Cross-Border US Comparisons

Some patients compare Canadian prices to US pricing, noting formulation name differences (albuterol vs salbutamol) and coverage variances.

Cross-border purchasing is limited by Canadian regulations and prescription requirements, and routine importation is not generally recommended.

Generic suppliers such as Teva and Sandoz help keep domestic pricing competitive.

In our online pharmacy, airomir is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Alternative Options

Comparison Table Of DIN-Approved Alternatives

Which products can be considered if Airomir is not suitable?

DIN-approved alternatives include Ventolin (GSK), Salamol, generics labelled as salbutamol/albuterol, levalbuterol where available, and terbutaline for select indications.

Pros And Cons Checklist

• Ventolin (GSK) — Proven track record and widespread availability.
• Generic albuterol (Teva, Sandoz, Mylan) — Lower cost with equivalent bronchodilation; excipients may vary.
• Levalbuterol — May have fewer cardiac side effects for some patients but is less available and more costly.
• Terbutaline — Alternative SABA with different pharmacologic profile and use cases.

Regulatory Status

Health Canada Approval Process

What regulatory checks ensure inhaler safety in Canada?

Health Canada requires evidence of quality, safety and efficacy for approval and assigns a Drug Identification Number (DIN) to marketed products.

Pharmacies must verify DINs for dispensing and for provincial formulary coverage decisions.

DIN And Bilingual Labelling Rules

Bilingual labelling in English and French and appropriate Patient Medication Leaflets are regulatory expectations for products supplied in Canada.

Post-market surveillance is conducted through Canada Vigilance, where adverse events are collected and serious events reported by manufacturers.

Consolidated FAQ

Can Airomir/Salbutamol Be Purchased Without A Prescription In Canada?

No — albuterol/salbutamol is prescription-only in most provinces, though pharmacists can sometimes provide emergency supplies under provincial rules.

How Many Puffs Per Canister And How Do I Know When It’s Empty?

Common MDIs are 200 actuations at 90 mcg per actuation; track doses or use a dose-counter if supplied rather than estimating by weight.

Is Albuterol Safe With Heart Conditions?

Use with caution in patients with arrhythmias or coronary artery disease and discuss alternatives and monitoring with the prescriber.

Can I Use A Spacer And Does It Change The Dose?

Yes — spacer use improves lung delivery and reduces throat deposition; the nominal MDI dose does not change although clinical delivery efficiency improves.

What If I’m Using SABA More Than Twice Per Week?

Frequent SABA use indicates suboptimal control and should prompt consultation with a healthcare provider to review controller therapy.

Visual Guide

What quick reference materials help patients and clinics?

Infographic elements should include a dosage strip (MDI 90 mcg per actuation; two puffs PRN; nebulizer adult 2.5 mg), a provincial coverage map highlighting ODB, BC PharmaCare and RAMQ, and a purchasing flowchart from prescription to dispensing.

Include a prominent warning panel for overdose signs — tachycardia, severe tremor and chest pain — and an MDI plus spacer quick-tech panel outlining shake, exhale, actuate, inhale slowly steps.

Designs must provide bilingual captions and be exportable as printable handouts for pharmacies.

Storage & Transport

Canadian Household Guidelines

How should patients store their inhaler at home?

Store MDIs at room temperature, ideally 15–25°C, away from direct heat and sunlight.

Do not expose canisters to temperatures above 120°F (49°C) and do not freeze, puncture or incinerate empty canisters.

During cold Canadian winters avoid leaving inhalers in very cold vehicles because propellant performance can be affected.

Cold-Chain Storage Where Applicable

Nebulizer solutions generally store at room temperature unless the manufacturer specifies refrigeration; pharmacies should check vial labelling and expiry dates.

When travelling, carry inhalers in hand luggage with prescription documentation to avoid temperature extremes in checked baggage.

Guidelines For Proper Use

Advice From Canadian Pharmacists

What do pharmacists check at each refill?

Check inhaler technique at every refill, encourage spacer use for children and those with poor technique, and document DIN and brand for continuity of care.

Pharmacist-led medication reviews can identify SABA overuse and trigger prescriber contact for treatment escalation.

Provincial Health Authority Guidance

Provincial asthma programs recommend written action plans pairing rescue inhaler use with clear escalation steps and controller adherence instructions.

Seek urgent care if SABA provides diminishing relief or if symptoms escalate despite inhaler use.

Delivery Across Canada (English)

Closing Practical Notes

Which key reminders should every patient leave the pharmacy with?

Always keep a written asthma action plan that states when to use rescue albuterol and when to seek urgent care.

Record the DIN and brand on your medication list to ensure consistent dispensing and provincial coverage.

Use a spacer for better delivery, count actuations or watch the dose counter, and seek a medication review when rescue inhaler use is frequent.

Overuse of rescue therapy is a clinical red flag that requires prescriber review and likely initiation or adjustment of controller therapy.